Platelet Inhibition and Bleeding in Patients Undergoing Emergent Cardiac Surgery

NCT01468597 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2020-06-18

Study results available
· View outcomes & findings →

Summary

The aim of the study is to evaluate if there is an association between platelet inhibition and surgery-related bleeding in patients undergoing emergent cardiac surgery during dual antiplatelet therapy.

Conditions

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Elisabeth Mahla, M.D. · Department of Anesthesia and Intensive Care Medicine, Medical University of Graz

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01468597 on ClinicalTrials.gov